In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.
Subscribe to:
Post Comments (Atom)
< + > Autonomous AI Is Transforming Healthcare Revenue Cycle Management
AKASA deploys generative AI along with human expertise to apply AI to the health care revenue cycle. In a recent interview at the AHIMA Ann...
No comments:
Post a Comment